DE3908749A1 - Herz- und kreislaufmedikament - Google Patents
Herz- und kreislaufmedikamentInfo
- Publication number
- DE3908749A1 DE3908749A1 DE19893908749 DE3908749A DE3908749A1 DE 3908749 A1 DE3908749 A1 DE 3908749A1 DE 19893908749 DE19893908749 DE 19893908749 DE 3908749 A DE3908749 A DE 3908749A DE 3908749 A1 DE3908749 A1 DE 3908749A1
- Authority
- DE
- Germany
- Prior art keywords
- osmium
- water
- cardiovascular medicine
- liquid
- hesperidin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/06—Benzopyran radicals
- C07H17/065—Benzo[b]pyrans
- C07H17/07—Benzo[b]pyran-4-ones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Description
Hesperidin flüssig 6 ml, Osmium
flüssig 21/2 ml - sollen zusammen
5 Minuten bei mittlerer Umdrehungs
zahl zentrifugiert werden. Dann
kann man das Präparat nach 10 Mi
nuten in Gebrauch nehmen.
Dieses Präparat kann angewendet werden bei immunologischen,
virologischen und bakteriologischen Entzündungen der Herz
kranzgefäße.
Wechselwirkungen sind i. M. nicht bekannt.
Claims (6)
- Hercolith - Handelsname und Waren bezeichnung
- Hesperidin 3 ml, verflüssigt in 3 ml destilliertem Wasser
- Osmium (Osmium-Säure - löslich in Wasser 7,24 Gramm bei 100 ml Wasser, bei +25 Grad Celsius) 1/2 ml Osmium (Osmium-Säure - löslich in Wasser, 7,24 Gramm bei 100 ml Wasser, bei +25 Grad Celsius) - verflüssigt in 2 ml destilliertem Wasser
- Hesperidin flüssig 6 ml
- Osmium flüssig 21/2 ml
- Gekennzeichnet durch Osmium
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19893908749 DE3908749A1 (de) | 1989-03-17 | 1989-03-17 | Herz- und kreislaufmedikament |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19893908749 DE3908749A1 (de) | 1989-03-17 | 1989-03-17 | Herz- und kreislaufmedikament |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3908749A1 true DE3908749A1 (de) | 1990-09-20 |
Family
ID=6376552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19893908749 Withdrawn DE3908749A1 (de) | 1989-03-17 | 1989-03-17 | Herz- und kreislaufmedikament |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE3908749A1 (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0543555A1 (de) * | 1991-11-18 | 1993-05-26 | Merrell Dow Pharmaceuticals Inc. | Phosphorylierte Flavonoide zur Behandlung von Viruserkrankungen |
-
1989
- 1989-03-17 DE DE19893908749 patent/DE3908749A1/de not_active Withdrawn
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0543555A1 (de) * | 1991-11-18 | 1993-05-26 | Merrell Dow Pharmaceuticals Inc. | Phosphorylierte Flavonoide zur Behandlung von Viruserkrankungen |
WO1993009786A1 (en) * | 1991-11-18 | 1993-05-27 | Merrell Dow Pharmaceuticals Inc. | Phosphorylated flavanoids in the treatment of viral diseases |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE69169T1 (de) | Kontrastmittel fuer ultraschalluntersuchungen und verfahren zu seiner herstellung. | |
JPS57159718A (en) | Novel protein and obtaining process | |
Hellberg et al. | Studies on the coronary microcirculation by direct visualization | |
DE3908749A1 (de) | Herz- und kreislaufmedikament | |
DE3879919D1 (de) | Verfahren zur herstellung von hexitolanhydriden, hexondactonen, hexosen und hexosiden. | |
Pawan et al. | Distribution of alcohol in urine and sweat after drinking | |
Bacchus | Serum seromucoid and acid mucopolysaccharide in the Marfan syndrome | |
BE789679A (fr) | Nouveaux derives d'acide amino-5 isophtalique et leurs procedesde preparation | |
Landis | Factors controlling the movement of fluid through the human capillary wall | |
ES2068527T3 (es) | Compuesto polisacaridico deslipidado, procedimiento de preparacion, composiciones que lo comprenden. | |
SU1270706A1 (ru) | Способ определени фосфолипидов в инфарктной зоне сердечной мышцы | |
WEST et al. | Effects of aortic insufficiency on circulatory dynamics of the dog: With special reference to coronary blood flow and cardiac oxygen consumption | |
Rosenblum | Erythrocyte velocity and fluorescein transit time in the cerebral microcirculation of macroglobulinemic mice: differential effect of a hyperviscosity syndrome on the passage of erythrocytes and plasma | |
EP0206551A3 (de) | 6-Jodiumethylierte Stärke und Verfahren zu deren Herstellung | |
BISHOP et al. | External rupture of the heart causing a systolic murmur and thrill | |
Braun et al. | Central blood volume, cardiac output, and pulmonary vascular pattern in mitral stenosis | |
Gauthier-Rahman et al. | Leukocyte migration inhibition in propranolol-induced pneumonitis: evidence for an immunologic cell-mediated mechanism | |
KR890002342A (ko) | 안트라퀴논계색소 및 이색소를 사용한 편광필름 | |
Donnelly | Congestive Heart Failure and Anemia: Report From Veterans Administration Hospital, Hines, Illinois | |
Ugarte et al. | Intracoronary platelet activation in ischemic heart disease: effects of ticlopidine | |
Orlova et al. | CONTENT OF SIALIC ACIDS IN TISSUES IN NORM AND AT EARLY STAGES OF MYOCARDIAL INFARCTION | |
이강호 | Chemical Modification of Fish Protein | |
Jokl et al. | Sudden cardiac death of pilots in flight. With special consideration of syncope due to silent ischemic heart disease and the differential diagnosis of other causes of episodes of incapacitation, unconsciousness, confusion and amnesia in flying personnel | |
BURCHELL et al. | Cardiac Isomers—A Pedagogic Exercise in the June Supplement | |
Hada et al. | Diffuse hypoplasia of the aorta as a possible cause of cardiac hypertrophy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8110 | Request for examination paragraph 44 | ||
8139 | Disposal/non-payment of the annual fee |